FLUID-BAG MULTI — superior logistics for liquid and semi-solid pharmaceutical products - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

FLUID-BAG MULTI – superior logistics for liquid and semi-solid pharmaceutical products

provides comprehensive 900 and 1000 litre flexible IBC systems for liquid and semi-solid products, including filling and discharging equipment. The GMP compliant container system is designed to guarantee uniform liquid, maximise payload and minimise discharge residue (0.5% residue).

The MULTI container combines the flexibility and space-saving advantages of both single-trip and multi-trip containers. The container consists of:

  • a replaceable, single-trip inner container
  • a reusable multi-trip transport bag
  • a reusable steel transport pallet with 4 steel poles.

Alternative liner combinations are available, gamma irradiation is also possible. The container can be used for external transports, intermediate storage, for transport between production, store room and packing department etc.

The FLUID-BAG system is used for storage and transportation of a wide range of liquids where protection from bacteria, particle, oxidation, taste or moisture contamination is needed. The containers are widely used for ointments, lotions, suspensions and other liquid or semi-solid products.

Contact details

Fluid-Bag Ltd
Bottenviksvägen 54-56
68600 Jakobstad
Finland
Tel. +358 20 779 0444
E-mail: office@fluid-bag.com
www.fluid-bag.com

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
FindPharma Custom Search

Click here